During cancer care, the body undergoes complex stress—
not only from the disease itself but also from the immune and neurological strain caused by treatments.
Beyond conventional interventions, a low-dose yet promising option is gaining attention:
Low Dose Naltrexone (LDN).
More than just a supplement—nutritional support for deeper systemic balance
Vitamin C is often thought of as a basic nutrient for daily health,
but under high-dose conditions, it plays a far more dynamic role—particularly in supportive care strategies aimed at enhancing resilience, detoxification, and cellular repair.
For those facing chronic stress, immune strain, or oxidative burden, high-dose vitamin C may serve as a critical tool for internal rebalancing.
You’ve probably heard of vitamin C, zinc, or omega-3s.
But if you’ve done a personalized cancer analysis like RGCC’s Onconomics Plus or Immune Frame,
you might have seen nutrient names that aren’t so familiar—
not your average supplements, but ones that are selected based on your unique cellular environment.
Behind these results lies a powerful concept:
Nutrition can—and should—be personalized.
For individuals who have experienced cancer, monitoring for recurrence or metastasis is a vital part of ongoing care.
While traditional imaging (like CT or MRI) can reveal tumor size and location, it often fails to detect the early biological activity of cancer cells.
This is where RGCC’s advanced circulating tumor cell (CTC) testing and genetic profiling offers a valuable advantage.
Onconomics Plus is an advanced personalized oncology assessment developed by RGCC.
In addition to testing the sensitivity of circulating tumor cells to various natural substances and pharmaceutical agents,
it also includes a range of key biomarkers closely associated with tumor behavior.
These biomarkers provide vital insights for designing personalized support strategies, risk evaluation, and ongoing monitoring.
IV Immunoglobulins (IVIG) are purified antibodies administered through an intravenous infusion. For cancer patients, especially those with hematologic malignancies or undergoing chemotherapy, IVIG is used as an immune support therapy to reduce infections, stabilize immune response, and improve resilience.
Among environmental toxins, heavy metals are often an overlooked yet deeply harmful group. Metals like lead, mercury, cadmium, and arsenic not only affect the nervous and immune systems but also directly damage our primary detoxification organs—the kidneys and liver. These two organs are vital for clearing metabolic waste and toxins, and once their function is compromised, the body’s overall health can become unbalanced.
Heavy metal exposure is an often-overlooked factor in chronic health conditions. While many people understand the neurotoxic effects of metals like lead, mercury, and cadmium, fewer realize how these metals can interfere with immune regulation. The immune system is a highly sensitive network designed to detect and neutralize threats—but when disrupted by toxins, it may become either underactive or dangerously overreactive.
In our modern environment, exposure to heavy metals such as lead, mercury, arsenic, aluminum, and cadmium has become increasingly common. While trace amounts of certain metals may play roles in biological function, toxic levels can severely damage multiple systems in the body—especially the nervous system. But how exactly do heavy metals harm the brain, nerves, and cognitive function? Let’s explore.
In palliative care, hope doesn’t disappear—it evolves. Instead of hoping for a cure, patients and families often begin to hope for things that are deeply meaningful:
– A day without pain
– A shared meal
– A moment of laughter
These are not small hopes—they are life-giving.